More Surufatinib Cheer For Chi-Med As Second NET Trial Stopped Early

Multi-Modal Candidate Meets Endpoint In Pancreatic Setting

 
• By Ian Haydock
  
Competitive edge and business advantage concept as a group of hot air balloons racing to the top but an individualleader with a small balloon attached giving the winning competitor an extra boost.
New Results Buoy Chi-Med • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapy Areas